Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-07

FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Slate Run Pharmaceuticals, LLC's generic diltiazem hydrochloride through an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride (generic) (Diltiazem hydrochloride)

Snippet

ORIG AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)